Gu, Juanjuan
Ternifi, Redouane
Sabeti, Soroosh
Larson, Nicholas B.
Carter, Jodi M.
Fazzio, Robert T.
Fatemi, Mostafa
Alizad, Azra
Funding for this research was provided by:
National Cancer Institute (R01CA239548, R01CA239548)
Article History
Received: 9 May 2022
Accepted: 18 November 2022
First Online: 30 November 2022
Declarations
:
: The Research involved human participants. The study received institutional review board approval (IRB#: 19-003028) and was Health Insurance Portability and Accountability Act (HIPAA) compliant. All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Signed IRB approved informed consent with permission for publication was obtained from all individual participants included in the study.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article and the authors affirm that they have no financial interest related to the technology referenced in this paper.